Articles by Michael Berk, MD, PhD

Telling Humanity’s Brain Story: Insights From Brain Capital
ByHarris A. Eyre, MD, PhD,Robert M. Lundin, BSc, MBBCh,Shuo Chen, JD,Ryan Abbott, MD, JD, PhD,Shekhar Saxena, MD,Stephen T. C. Wong, PhD,James T. Hackett,William Hynes, DPhil,Daniela Schiller, PhD,Nancy Mannix, JD,Serena Jenkins, PhD,Claire Neihaus, MSc,Walter D. Dawson, DPhil,Michael Berk, MD, PhD Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?

Building Brain Resilience: A Multi-Level Systems Approach
ByDavid G. Angeler, PhD,Robert M. Lundin, BSc, MBBCh,Richard G. Hunter, PhD,Erin Smith,Andrew Wister, PhD,William Hynes, DPhil,Michael Berk, MD, PhD,Helen Lavretsky, MD, MS,Benjamin Trump, PhD,Igor Linkov, PhD, MSc,Charles Benight, PhD,Nadia Estafany,Sebastian F. Winter, MD, PhD,Theodore Edmonds, JD,Cameron Lister, MPH,Eric A. Storch, PhD,Michael D. Matthews, PhD,Harris A. Eyre, MD, PhD Beyond the COVID-19-driven shock, we must develop a resilient future in an increasingly uncertain world.

Advancing Brain Capital: Achievements, Lessons, and Next Steps
ByHarris A. Eyre, MD, PhD,William Hynes, DPhil,Michael Berk, MD, PhD,Erin Smith,Jeffrey L. Cummings, MD, ScD A transdisciplinary team summarizes key points and reflections after 18 months of activity.

Cybercriminal Exploitation of Cognitive Biases: A Brain Capital Perspective
ByIan MacRae, MSc,Rashi Ojha, MD,Erin Smith,Daniel Krawczyk, PhD,Michael Berk, MD, PhD,Harris A. Eyre, MD, PhD How prioritizing brain health and brain skills could offer new solutions to this challenge.

Mind-Body Resilience for Women: A Focus on Depression
ByErin Smith,Mark Heinemeyer,Sandra Bond Chapman, PhD,Paul Zarutskie, MD,Zoe Wainer, MBBS, PhD,Michael Berk, MD, PhD,Antonella Santuccione Chadha, MD,Harris A. Eyre, MD, PhD Here’s why we should be paying special attention to women's depression treatment.

Brain Capital: An Emerging Investment Opportunity
ByHarris A. Eyre, MD, PhD,Mark Faulkenberg,Sanjiv Das,James T. Hackett,Shuo Chen, JD,Francois Véron,Pawel Swieboda,Geoffrey S.F. Ling, MD, PhD,Eric W. Bennett,Shekhar Saxena, MD,Steve Carnevale,Ethan Powell,Erin Smith,Agustin Ibañez, PhD,Stephen T. Wong, PhD,Eric A. Storch, PhD,Evelyn Chan, MBBS, MSc,Mark Heinemeyer,Ian Robertson, PhD,Walter D. Dawson, DPhil,Dapo Tomori, MD,Jair C. Soares, MD,Ryan Abbott, MD, JD, PhD,Sebastian F. Winter, MD,Sandra Bond Chapman, PhD,Anastasia Budinskaya, MSc,Lisa Brown, PhD,Lynne Corner, PhD,Kirk Nylen, PhD,Garth Smith, PhD,Tom Mikkelsen, MD,Michael Berk, MD, PhD Brain Capital: a fresh approach to technologies and investing.

Brain Capital Foundry: Accelerating Responsible Innovation
ByErin Smith,Walter D. Dawson, DPhil,James T. Hackett,Stephen T. Wong, PhD,Francois Véron,Michael Berk, MD, PhD,William Hynes, DPhil,Andy Keller, PhD,Ernestine Fu, PhD,Shuo Chen, JD,Harris A. Eyre, MD, PhD How can this new model help us link brain-based innovation with economics?

Avoiding a Brain Health Innovation Market Failure: Lessons from the Hype Cycle
ByHenry Asher,Erin Smith,Mark Heinemeyer,Michael Berk, MD, PhD,Agustin Ibañez, PhD,Shuo Chen, JD,Ernestine Fu, PhD,Jessica Wolfe, PhD, MPH,Ryan Abbott, MD, JD, PhD,Francois Véron,William Ellsworth,Marion Leboyer, MD, PhD,Geoffrey S.F. Ling, MD, PhD,Igor Linkov, PhD, MSc,Magali Haas, MD, PhD,Harris A. Eyre, MD, PhD New approaches to ensure that the brain health technology sector continues to flourish for decades.

Sustaining Investment in Brain Health: The Dangers of Information Asymmetry
ByErin Smith,Mark Heinemeyer,Jessica Wolfe, PhD, MPH,Henry Asher,Ryan Abbott, MD, JD, PhD,William Hynes, DPhil,Gowri G. Aragam, MD,Ernestine Fu, PhD,Francois Véron,Michael Berk, MD, PhD,Shuo Chen, JD,Mike Lyons, PhD,William Ellsworth,Harris A. Eyre, MD, PhD Information asymmetry occurs when one party has more or better information than the other party. Asymmetry and fraud will sour investor interest in the field.

Let’s Build Brains Better! Brain Science-Inspired Policies for the Future
ByErin Smith,William Hynes, DPhil,Jorge Jraissati,Michael Hogan,Lori Rubenstein,Ernestine Fu, PhD,Eric A. Storch, PhD,Kunmi Sobowale, MD,Laura Jana, MD,Michael Berk, MD, PhD,Harris A. Eyre, MD, PhD In order to face the rapidly changing, increasingly complex, and globally connected world, we need to focus on the importance of early brain and child development.

Anthropology-Informed Business Principles for Brain Health
ByErin Smith,Eric J. Lenze, MD,Gowri G. Aragam, MD,Scott Kaiser, MD,Ernestine Fu, PhD,Marion Leboyer, MD, PhD,Shuo Chen, JD,Michael Berk, MD, PhD,Mark Heinemeyer,Harris A. Eyre, MD, PhD The key to addressing mental health may lie in business innovation theories.

Boosting Brain Health After COVID-19: A Convergence Solution
ByHarris A. Eyre, MD, PhD,Jessica Carson,Erin Smith,Helen Lavretsky, MD, MS,Charles F. Reynolds III, MD,Husseini K. Manji, MD,Walter D. Dawson, DPhil,Laura Booi, PhD,Mark Heinemeyer,Jeffrey L. Cummings, MD, ScD,Ernestine Fu, PhD,Eric A. Storch, PhD,William Hynes, DPhil,Eric J. Lenze, MD,Retsina Meyer, PhD,Ian Macrae, PhD,Antonella Santuccione Chadha, MD,Ryan Abbott, MD, JD, PhD,Sandra Bond Chapman, PhD,Ian Robertson, PhD,Carol Graham,Brisa S. Fernandes, MD, MSc, PhD,David G. Angeler, PhD,Adrienne Grzenda, MD, PhD,Agustin Ibañez, PhD,Zoltan Sarnyai, MD, PhD,Sofia Marcha,Michael Berk, MD, PhD,Patrick Brannelly How can we face the current pandemic while addressing the brain health crisis?

Feeling Lucky? Convergence Mental Health as a Mechanism for Serendipitous Innovation
ByErin Smith,Jessica Carson,Rebecca Leaman,William Hynes, DPhil,Helen Lavretsky, MD, MS,Michael Berk, MD, PhD,Harris A. Eyre, MD, PhD This mindset might be the key to mental health breakthroughs.

Preliminary studies suggest that adjuvant treatment with a statin may be beneficial for patients who are also prescribed psychotropic drugs for depression and schizophrenia.

Exploring N-Acetylcysteine in Psychiatry
ByAnna Giménez-Palomo, MD,Seetal M. Dodd, PhD,Olivia M. Dean, PhD,Chiara Bortolasci, MSc, PhD,Michael Berk, MD, PhD A synthetic derivate of the endogenous amino acid L-cysteine and a precursor of glutathion, N-Acetylcysteine shows promise for treating a variety of psychiatric disorders.

Convergence Mental Health: A New Pathway for Transdisciplinary Innovation and Entrepreneurship
ByErin Smith,William Ellsworth,Charles F. Reynolds III, MD,Michael Berk, MD, PhD,Harris A. Eyre, MD, PhD,Helen Lavretsky, MD, MS A paradigm shift is needed in order to solve the unprecedented complexities and challenges associated with the current global mental health crisis.